1
![Turning Point Therapeutics]()
![Turning Point Therapeutics]()
![Turning Point Therapeutics]()
Turning Point Therapeutics
Leadership team
J. Jean Cui (Founder)
Y. Peter Li (Founder)
Products/ Services
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Number of Employees
100 - 500
Headquarters
San Diego, California, United States
Established
2013
Company Registration
SEC CIK number: 0001595893
Traded as
NASDAQ:TPTX
Overview
Location
Summary
Turning Point Therapeutics, Inc. is a clinical-stage precision oncology company with a robust pipeline of internally developed drug candidates. The company is focused on discovering and developing novel therapies to address key limitations of existing treatments, including the emergence of drug resistance, to significantly improve the lives of patients with cancer.
History
Headquartered in San Diego, California, Turning Point Therapeutics was founded in 2013 by a team of oncology scientists from La Jolla Pharmaceuticals. The company is actively researching and developing novel and targeted therapies targeting newly identified genetic and epigenetic alterations in cancer cells.
Mission
Turning Point Therapeutics’ mission is to discover and develop precision oncology therapies to improve the lives of our patients and improve their clinical outcomes.
Vision
Turning Point Therapeutics pursues a vision of a world in which early, targeted treatments are the standard of care for cancer, allowing people to live longer, healthier lives.
Key Team
J. Jean Cui (Founder)
Y. Peter Li (Founder)
Recognition and Awards
Turning Point Therapeutics was recognized by FierceBiotech as one of the “Fierce 15” in 2020, an award given to the 15 most promising private biotechnology companies in the world.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
J. Jean Cui (Founder)
Y. Peter Li (Founder)
Products/ Services
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Number of Employees
100 - 500
Headquarters
San Diego, California, United States
Established
2013
Company Registration
SEC CIK number: 0001595893
Traded as
NASDAQ:TPTX